Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Auxilium Pharmaceuticals (AUXL)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for AUXL as compared to
Top Competitors
Drug Related Products.
Drug Related Products
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
151M
AVG
Number of Licenses
►
4.00
AVG
R&D Expense
►
42.8M
HIGH
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
151M
AVG
EBITDA
►
-37.2M
LOW
Net Income
►
-53.7M
LOW
Revenue Growth
►
27.4%
HIGH
Operating Margin
►
-27%
AVG
Net Margin
►
-35.6%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
1.06
HIGH
Current Ratio
►
3.95
HIGH
Quick Ratio
►
3.75
HIGH
Interest Coverage Ratio
►
-204
VERY LOW
Book Value Per Share
►
2.68
Cash Per Share
►
4.10
Loading...
STOCK SUMMARY
Open
Day Range
-
52 Week Range
-
Volume
Avg Volume (3 mo)
Shares Outstanding
Market Cap
VALUATION
Price to Earnings (P/E)
►
-29.6
Price to Book (P/B)
►
12.6
VERY HIGH
Price to Sales (P/S)
►
10.5
VERY HIGH
Return on Assets (ROA)
►
-30.5%
AVG
Return on Equity (ROE)
►
-64.2%
AVG
EV/EBITDA
►
-47.9
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-0.4%
Net Insider Buying 6mo
-0.7%
Net Insider Buying 1yr
-1.4%
Held by insiders
6.8%
Held by institutions
24.9%